Reply to: Benefits of cannabis use for metabolic disorders and survival in people living with HIV with or without hepatitis C
AIDS
.
2020 May 1;34(6):955-956.
doi: 10.1097/QAD.0000000000002481.
Authors
Cecilia T Costiniuk
1
2
3
4
,
Mohammad-Ali Jenabian
4
5
6
Affiliations
1
Chronic Viral Illness Service and Division of Infectious Diseases, Department of Medicine.
2
Infectious Diseases and Immunity in Global Health Program, Research Institute of McGill University Health Centre.
3
McGill Research Centre for Cannabis and The Mark Wainberg Centre for Viral Diseases.
4
Department of Microbiology and Immunology, McGill University.
5
Department of Biological Sciences, University of Quebec at Montreal (UQAM).
6
Department of Microbiology, Infectiology and Immunology, Faculty of Medicine, University of Montreal, Montreal, QC, Canada.
PMID:
32271255
DOI:
10.1097/QAD.0000000000002481
No abstract available
Publication types
Comment
MeSH terms
Cannabinoids*
Cannabis*
HIV Infections*
Hepatitis C*
Humans
Inflammation
Metabolic Diseases*
Substances
Cannabinoids